Identification |
Name: | Ethanaminium,2-[(2,6-dimethylphenyl)amino]-N,N,N-triethyl-2-oxo- |
Synonyms: | Ammonium,triethyl[(2,6-xylylcarbamoyl)methyl]- (8CI);QX 314; |
CAS: | 21306-56-9 |
Molecular Formula: | C16H27N2O |
Molecular Weight: | 343.3 |
InChI: | InChI=1/C16H26N2O.BrH/c1-6-18(7-2,8-3)12-15(19)17-16-13(4)10-9-11-14(16)5;/h9-11H,6-8,12H2,1-5H3;1H |
Molecular Structure: |
|
Properties |
Flash Point: | °C |
Boiling Point: | °Cat760mmHg |
Density: | g/cm3 |
Specification: | Safety Statements:26-36 26:In case of contact with eyes, rinse immediately with plenty
of water and seek medical advice 36:Wear suitable protective clothing |
Biological Activity: | Membrane impermeable quaternary derivative of lidocaine, a blocker of voltage-activated Na + channels. Intracellular QX 314 bromide also inhibits calcium currents in hippocampal CA1 pyramidal neurons. |
Flash Point: | °C |
Storage Temperature: | Desiccate at RT |
Safety Data |
Hazard Symbols |
Xi: Irritant
|
|
|